-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-market session. The company's market cap stands at $22.1 million.
  • Catheter Precision (AMEX:VTAK) shares rose 44.56% to $1.33. The company's market cap stands at $2.4 million.
  • Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock rose 34.77% to $5.31. The company's market cap stands at $10.5 million.
  • Evogene (NASDAQ:EVGN) stock increased by 28.3% to $0.63. The market value of their outstanding shares is at $5.9 million.
  • Absci (NASDAQ:ABSI) stock increased by 26.31% to $9.36. The company's market cap stands at $1.1 billion.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 26.15% to $4.1. The market value of their outstanding shares is at $6.5 million.

Losers

  • Nuwellis (NASDAQ:NUWE) stock declined by 31.9% to $0.09 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million.
  • Mobile-health Network (NASDAQ:MNDR) stock decreased by 24.6% to $0.43. The company's market cap stands at $4.0 million.
  • Profusa (NASDAQ:PFSA) stock declined by 20.98% to $0.11.
  • AN2 Therapeutics (NASDAQ:ANTX) stock decreased by 14.66% to $4.25. The company's market cap stands at $179.3 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 14.48% to $2.6. The company's market cap stands at $1.9 million.
  • Atlantic International (NASDAQ:ATLN) shares fell 13.54% to $1.15. The market value of their outstanding shares is at $101.3 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending